Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valeria Relli
Observed names:
Relli, Valeria,
V Relli,
V. Relli
Institution:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Observed institutions:
University of Chieti-Pescara,
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Achieve Life Sciences (Canada),
Oncolytics Biotech (Canada),
University of Bologna
ORCID:
0000-0001-6199-3470
Observed ORCID:
0000-0001-6199-3470
OpenAlex ID:
A5060075466
Abandoning the Notion of Non-Small Cell Lung Cancer
2019
·
Valeria Relli
, Marco Trerotola
, et al.
·
Trends in Molecular Medicine
·
511
Epigenetic inheritance and the missing heritability
2015
·
Marco Trerotola
, Valeria Relli
, et al.
·
Human Genomics
·
388
PDF
Trop-2 Is a Determinant of Breast Cancer Survival
2014
·
Federico Ambrogi
, Marco Fornili
, et al.
·
PLoS ONE
·
241
PDF
Trop-2 Induces Tumor Growth Through AKT and Determines Sensitivity to AKT Inhibitors
2016
·
Emanuela Guerra
, Marco Trerotola
, et al.
·
Clinical Cancer Research
·
67
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer
2021
·
Emanuela Guerra
, Marco Trerotola
, et al.
·
Neoplasia
·
55
PDF
Distinct lung cancer subtypes associate to distinct drivers of tumor progression
2018
·
Valeria Relli
, Marco Trerotola
, et al.
·
Oncotarget
·
43
PDF
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion
2022
·
Emanuela Guerra
, Valeria Relli
, et al.
·
Oncogene
·
32
PDF
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
2023
·
Emanuela Guerra
, Marco Trerotola
, et al.
·
Molecular Cancer Therapeutics
·
20
Molecular hydrogen therapy: A “democratic” emerging strategy against aging and age-related diseases
2025
·
Giovanni Brandi
, Chiara Delbaldo
, et al.
·
Ageing Research Reviews
·
11
Molecular Features and Targeted Therapies in Extrahepatic Cholangiocarcinoma: Promises and Failures
2020
·
Alessandro Rizzo
, Simona Tavolari
, et al.
·
Cancers
·
11
PDF
Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies
2024
·
Giovanni Brandi
, Valeria Relli
, et al.
·
Scientific Reports
·
9
Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster
2020
·
Giovanni Brandi
, Alessandro Rizzo
, et al.
·
BMC Medical Genetics
·
9
PDF
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody
2023
·
Emanuela Guerra
, Marco Trerotola
, et al.
·
Cancers
·
6
PDF
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks
2024
·
Emanuela Guerra
, Marco Trerotola
, et al.
·
Frontiers in Genetics
·
2
Asbestos exposure as an additional risk factor for small duct intrahepatic cholangiocarcinoma: a pilot study
2023
·
Francesco Vasuri
, Marzia Deserti
, et al.
·
Scientific Reports
·
2
The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial–mesenchymal transition in triple-negative breast cancer cells
2026
·
Marzia Deserti
, Simone Sabbioni
, et al.
·
Frontiers in Oncology
·
1
PDF
Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma Patients
2025
·
Marzia Deserti
, Valeria Relli
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Large, recursive membrane platforms are associated to Trop-1, Trop-2, and protein kinase signaling for cell growth
2025
·
Marco Trerotola
, Valeria Relli
, et al.
·
Molecular Biology of the Cell
·
1
PDF
Abstract 367: Trop-2 activates a dormant Na+/K+-ATPase/PKCα/CD9/ezrin signaling axis to override the basal growth program of cancer cells
2017
·
Marco Trerotola
, Valeria Relli
, et al.
·
Cancer Research
·
1
Supplementary Online Material from 3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
2025
·
Emanuela Guerra
, Marco Trerotola
, et al.
PDF
Movie S1 from 3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability
2025
·
Emanuela Guerra
, Marco Trerotola
, et al.
Supplementary Online Material from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024
·
Emanuela Guerra
, Marco Trerotola
, et al.
Movie S1 from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024
·
Emanuela Guerra
, Marco Trerotola
, et al.
Data from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024
·
Emanuela Guerra
, Marco Trerotola
, et al.
Movie S1 from 3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability
2024
·
Emanuela Guerra
, Marco Trerotola
, et al.
Show more works
View as search
Works count:
52
Citation count:
1,411
H-index:
10
I10-index:
10
Year
Topic
Type